Discovery Series – Women’s Health: BHRT and Female Sexual Dysfunction

Presented by RxHarmony clinical team in partnership with Revelation Pharma

Women’s health is where compounded therapy earns its keep. In this Discovery Series session, delivered in partnership with Revelation Pharma, your team gets a complete tour of the BHRT and Female Sexual Dysfunction programs your practice can offer — and the clinical frameworks that make prescribing feel simple.

The session starts with the foundations of compounding and a clear walk through the steroid hormone cascade so every clinician on your team understands why the right hormone at the right dose in the right delivery vehicle produces the outcomes patients are asking for. From there, the discussion moves into estrogen therapy — E1, E2, and E3, the Biest formulations, the strengths, and the SIG — followed by progesterone, testosterone (sublingual and topical), vaginal preparations, and porcine thyroid.

The second half turns to Female Sexual Dysfunction — a conversation many practices avoid because they don’t have a clinical framework to structure it. This session gives you one: a flow chart that separates HSDD, arousal disorders, vestibulodynia, and related presentations, with the compounded options that match each pathway. The discussion also covers the DIM Matrix supplement and where it fits inside a broader hormone-balance plan.

If you have patients navigating perimenopause, menopause, or intimacy concerns they’ve been quietly hoping you’d address, this session gives your team the vocabulary, the clinical structure, and the confidence to lead those conversations.

This presentation is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Compounded medications are not FDA-approved and may differ from FDA-approved products in safety, quality, or effectiveness. All clinical decisions remain the sole responsibility of the prescribing healthcare provider. Individual results may vary.